IL37976A - Crystalline hydrate of trisodium d-fructose-1,6-diphosphoric acid and process for the preparation thereof - Google Patents

Crystalline hydrate of trisodium d-fructose-1,6-diphosphoric acid and process for the preparation thereof

Info

Publication number
IL37976A
IL37976A IL37976A IL3797671A IL37976A IL 37976 A IL37976 A IL 37976A IL 37976 A IL37976 A IL 37976A IL 3797671 A IL3797671 A IL 3797671A IL 37976 A IL37976 A IL 37976A
Authority
IL
Israel
Prior art keywords
aqueous solution
acid
fructose
process according
preparation
Prior art date
Application number
IL37976A
Other versions
IL37976A0 (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19702061731 external-priority patent/DE2061731C/en
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL37976A0 publication Critical patent/IL37976A0/en
Publication of IL37976A publication Critical patent/IL37976A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Description

CRYSTALLINE HYDRATE OF TRIS DIUM ACID AND PROCESS FOR THE PREPARATION The present invention is concerned with a crystalline hydrate of acid a process for the preparation acid was first isolated by Young in especially in the form of its sodium is used pharmaceutically in the treatment of various metabolic Although the sodium salt of diphosphoric acid has been known a long time and is prepared on a large it ha3 hitherto never been possible to convert the salt into a crystallised in the case of the known production a solution of sodium acid is obtained in the laet hitherto the compound has had to be converted into a solid form by processes such as precipitation with organic spray drying or freeze the amorphous product obtained by any of the known processes is extremely hygroscopic and becomes lumpy or deliquesces in the Due to these properties of the considerable difficulties arise during despatch and working especially galenical preparations are to be made in solid we now found under certain the trisodium salt of diphosphoric acid can be crystallised as the the present invention provides crystalline sodium acid octahydrate as a new The trisodium acid according to the present invention is in the form of inonoclinic crystals of the spatial group with the cell dimensions a and c and angle β The crystalline octahydrate according to the present invention is no longer hygroscopic in comparison with the previously known amorphous has a considerably greater According to the present there is also provided a process the preparation of crystalline trisodium acid wherein a dilute aqueous solution of diphosphoric acid in the form its sodium salt is adjusted to a value between and preferably between mixed at 15 to with a lower alkanol until the commencement of turbidity cooled until crystal formation mixed further alkanol in an amount of up to 2 to 3 times the volume of the initial aqueous solution and the crystal formation completed at a reduced The aqueous starting solution used preferably has a content of trisodium acid of about 7 to The pH value of the initial aqueous solution is preferably adjusted with a sodium hydroxide solution with an the sodium salt of which has at least a certain degree of solubility in the alkanol A preferred acid for this purpose for acetic After adjustment of the pH the solution if clarified by By lower according to the present invention there is to be understood an alkanol containing up to 3 carbon ethanol being it is possible to use or isopropanol in the case of the latter crystal formation is less the yield is lower and the product obtained sometimes contains and thus hygroscopi The alkanol is preferably added at ambient temperatu until a slight turbidity The solution is then slowly further cooled until the commencement of crystallis ation can be As soon as the first visible crystals are further alkanol is preferably up to a fold volume of referred to the initia volume of the aqueous For completion of the the solution is further for example by placing in a ref igerato In the case of a temperature of about and with the us of a fold volume of crystallisation is ended after 20 to o The crystalline product can be separated by the usual physical then washed with alcohol and The mother liquor at to of the sodium salt initially When temperatures above are preferably avoided in order to prevent the loss of water of crystalli ation or a destruction of the crystal Drying agents which vigorously remove for phosphorus are preferably also not accompanying photographs Λ and B show the crysta The following Example is given for the purpose of illustrating the present Example 100 amorphous trisodium acid are dissolved in 900 distilled The pH value of the solution is adjusted to the addition of acetic acid and then filtered through a Ethanol is now added in a thin stream until turbidity can be This is the case after the addition of about 700 The solution is placed in a refrigerator of After crystallisation A 800 alcohol are then with After the crystal slurry which in the formed is off with suction the crystals are stirred up with 500 again ltered with suction and then dried in a vacuum drying cabinet at without the use of a drying There are trisodium diphosphoric acid In the mother 6 of the trisodium can be detected Properties of the Sum Melting point Molecular weight t found enzymatically sodium found water found phosphorus optical rotation water cryatallographic crystal system monoclin spatial group 21 cell dimensions a c angle 157 insufficientOCRQuality

Claims (10)

What we claim is :~
1. Ci'ystalline trisodium • acid octahydrate.
2. . Crystals according to crystals of spatial group P , b = 11.651 and c = 7.1 £ and angle /? = 108°.
3. Process for the preparation of crystals according to claim , wherein a dilute aqueous solution of D-fructose- the initial aqueous solution and the crystal formation completed at a reduced temperature.
4. Process according to claim 3, wherein" the initial aqueous solution is adjusted to a pH of 5.9;.to 6.1.
5. Process according to claim 3 or k, wherein the pH value of the initial aqueous solution is adjusted with sodium hydroxide solution or with an acid, the sodium salt of which is soluble in the alkanol used.
6. Process according to any of claims 3 - 5, wherein the initial aqueous solution contains 7 to 13 of D- fructose- ,6-diphosphoric acid sodium salt.
7. Process according to any of claims 3 - 6, wherein the lower alkanol used is ethanol.
8. Process according to any of claims 3 - 7, wherein the further alkanol is added in an amount of up to 1,5 times the volume, referred to the volume of the initial aqueous solution.
9. ' Process for the preparation of crystals according to claim 1 , substantially as hereinbefore described and exemplif ed.
10. / .Crystalline tri sodium D-fructose-1 ,6-diphosphoric acid octahydrate, whenever prepared by the process according to any of claims 3 ~ 9. Attorney for Applicants
IL37976A 1970-12-15 1971-10-20 Crystalline hydrate of trisodium d-fructose-1,6-diphosphoric acid and process for the preparation thereof IL37976A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702061731 DE2061731C (en) 1970-12-15 Monoclinic trisodium D-fructose-1,6-diphosphoric acid octahydrate and process for its preparation

Publications (2)

Publication Number Publication Date
IL37976A0 IL37976A0 (en) 1971-12-29
IL37976A true IL37976A (en) 1974-06-30

Family

ID=5791050

Family Applications (1)

Application Number Title Priority Date Filing Date
IL37976A IL37976A (en) 1970-12-15 1971-10-20 Crystalline hydrate of trisodium d-fructose-1,6-diphosphoric acid and process for the preparation thereof

Country Status (7)

Country Link
JP (1) JPS5126417B1 (en)
FR (1) FR2118103B1 (en)
GB (1) GB1313720A (en)
HU (1) HU163084B (en)
IL (1) IL37976A (en)
NL (1) NL7115376A (en)
SU (1) SU452964A3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102127426A (en) * 2011-01-11 2011-07-20 宁波大学 Fluorescent material with purple luminescence property and preparation method thereof

Also Published As

Publication number Publication date
GB1313720A (en) 1973-04-18
FR2118103B1 (en) 1975-06-13
FR2118103A1 (en) 1972-07-28
SU452964A3 (en) 1974-12-05
JPS5126417B1 (en) 1976-08-06
NL7115376A (en) 1972-06-19
IL37976A0 (en) 1971-12-29
DE2061731A1 (en) 1972-03-16
HU163084B (en) 1973-06-28

Similar Documents

Publication Publication Date Title
US4775751A (en) Process for cephalexin hydrochloride alcoholates
JPS59130888A (en) Crystalline cephem-acid addition salt and manufacture
US4456753A (en) Process for the manufacture of highly crystalline sodium cefoperazone
JPS63280100A (en) Crystalline human proinsulin and manufacture
NO151748B (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL ACCEPTABLE, NON-SOLVATED, WATER-FREE, GAMMA CRYSTALLINIC FORM OF SODRIM-7- (D-ALFA-FORMYLOXY-ALFA-PHENYLACETAMIDO) -3- (1-METHYL-METHYL-YL-METHYL-H-METHYL-YL-METHYL-1-METHYL-METHYL-METHYL) 3-cephem-4-carboxylate
US4104470A (en) Crystallization process for cefazolin sodium
CN111471057A (en) Process for preparing mezlocillin sodium by solvent crystallization
IL37976A (en) Crystalline hydrate of trisodium d-fructose-1,6-diphosphoric acid and process for the preparation thereof
US4054738A (en) Sodium cefamandole crystalline forms
CN108586491B (en) Preparation method of cefetamet pivoxil hydrochloride
US2729642A (en) Water soluble salts of 8-(para-aminobenzyl) caffeine and method for their preparation
EP0450684B1 (en) A process for the preparation of D-(-)-4-hydroxyphenylglycine and L-(+)-4-hydroxyphenylglycine, starting from D.L.-4-hydroxyphenylglycine
US5480982A (en) Crystalline potassium salt of thinonicotinamide adenine dinucleotide phosphate
Keats 332. The stereochemistry of thianthren
SU860705A3 (en) Method of preparing crystalline form of d-configuration of diammonium salt of 7-beta-/-alpha-carboxy-alpha-p-oxyphenyl acetamido /-7-alpha-methoxy-3-(1-methyltetrazol-5-yl)-thiomethyl-1-oxydethia-3-cephem-4-carboxalic acid
US4115644A (en) Process for preparing pure cefamandole from alkali metal and ammonium salts thereof
US3983109A (en) Process for recovering cephalosporin C from A fermentation broth as the N-(p-nitrobenzoyl) derivative
US2891051A (en) Adducts of salts of novobiocin
JP2877366B2 (en) Method for producing crystalline L-ascorbic acid-2-phosphate sodium salt
JPS59111917A (en) Manufacture of aluminum polyhydroxide complex crystal
US1997719A (en) Hydroxyexhyldebydrocijpreine
US2680739A (en) Production of sodium penicillin
US3016385A (en) Method of preparing glyoxal hydrate
US2686749A (en) Process for purifying neomycin
CA1089446A (en) Sodium cefamandole crystalline forms